Susquehanna International Group, LLP Medpace Holdings, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$320.58 - $457.29 $19.2 Million - $27.4 Million	60,000 Added 233.46%	85,700 $28.6 Million
Q2 2024 Aug 15, 2024	BUY	$372.0 - $424.34 $5.43 Million - $6.2 Million	14,600 Added 131.53%	25,700 $10.6 Million
Q1 2024 May 07, 2024	BUY	$284.87 - $413.31 $797,636 - $1.16 Million	2,800 Added 33.73%	11,100 $4.49 Million
Q4 2023 Feb 14, 2024	BUY	$227.52 - $312.68 $409,536 - $562,824	1,800 Added 27.69%	8,300 $2.54 Million
Q3 2023 Nov 14, 2023	SELL	$233.98 - $281.67 $3.44 Million - $4.14 Million	-14,700 Reduced 69.34%	6,500 $1.57 Million
Q2 2023 Aug 11, 2023	BUY	$187.26 - $240.17 $2.34 Million - $3 Million	12,500 Added 143.68%	21,200 $5.09 Million
Q1 2023 May 16, 2023	SELL	$174.31 - $239.52 $1.06 Million - $1.46 Million	-6,100 Reduced 41.22%	8,700 $1.64 Million
Q4 2022 Feb 14, 2023	SELL	$153.06 - $226.57 $2.22 Million - $3.29 Million	-14,500 Reduced 49.49%	14,800 $3.14 Million
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $261,234 - $328,482	1,800 Added 6.55%	29,300 $4.61 Million

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $9.66B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.